View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Horton D R Inc: 1 director

A director at Horton D R Inc sold 5,650 shares at 163.100USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

Brian Violino ... (+2)
  • Brian Violino
  • Jay McCanless
 PRESS RELEASE

D.R. Horton, Inc., America’s Builder, Reports Fourth Quarter and Fisca...

ARLINGTON, Texas--(BUSINESS WIRE)-- D.R. Horton, Inc. (NYSE:DHI): Fiscal 2024 Fourth Quarter Highlights Earnings per diluted share were $3.92 on net income of $1.3 billion Consolidated pre-tax income of $1.7 billion, with a pre-tax profit margin of 17.1% Consolidated revenues of $10.0 billion Home sales revenues of $8.9 billion on 23,647 homes closed Fiscal 2024 Highlights - comparisons to the prior year Earnings per diluted share increased 4% to $14.34 on net income of $4.8 billion Consolidated pre-tax income of $6.3 billion, with a pre-tax profit margin of 17.1% Consolidated...

Brian Violino ... (+2)
  • Brian Violino
  • Jay McCanless
Brian Violino ... (+2)
  • Brian Violino
  • Jay McCanless
 PRESS RELEASE

D.R. Horton, Inc. to Release 2024 Fourth Quarter and Fiscal Year-End E...

ARLINGTON, Texas--(BUSINESS WIRE)-- (NYSE:DHI), America’s Builder, announced today that the Company will release financial results for its fourth quarter and fiscal year ended September 30, 2024 on Tuesday, October 29, 2024 before the market opens. The Company will host a conference call that morning at 8:30 a.m. Eastern Time (ET). The dial-in number is 888-506-0062. When calling, please reference access code 584166. Participants are encouraged to call in five minutes before the call begins (8:25 a.m. ET). The call will also be webcast from the Company’s website at . A replay of the call wi...

 PRESS RELEASE

D.R. Horton, Inc. Appoints Three New Independent Directors

ARLINGTON, Texas--(BUSINESS WIRE)-- (NYSE: DHI), America’s Builder, announced today that its Board of Directors (the “Board”) has appointed three new independent directors – Barbara R. Smith, M. Chad Crow and Elaine D. Crowley – effective August 26, 2024. As part of the Company's succession planning and commitment to ensuring strong Board composition, the three newly appointed directors each bring valuable experience and insight to the D.R. Horton Board. Each appointee has an excellent professional resume that adds to the qualifications, experiences and characteristics of the Company’s curr...

 PRESS RELEASE

D.R. Horton, Inc. Announces Pricing of $700 Million of 5.000% Senior N...

ARLINGTON, Texas--(BUSINESS WIRE)-- D.R. Horton, Inc. (“D.R. Horton” or the “Company”) (NYSE:DHI), America’s Builder, announced that it has priced a registered underwritten public offering of $700 million aggregate principal amount of 5.000% senior notes due 2034. The senior notes will pay interest semi-annually at a rate of 5.000% per year and will mature on October 15, 2034. The closing of the offering is expected to occur on August 14, 2024, subject to the satisfaction of customary closing conditions. D.R. Horton intends to use the net proceeds of the offering for general corporate purposes...

 PRESS RELEASE

D.R. Horton, Inc., America’s Builder, Reports Fiscal 2024 Third Quarte...

ARLINGTON, Texas--(BUSINESS WIRE)-- D.R. Horton, Inc. (NYSE:DHI): Fiscal 2024 Third Quarter Highlights - comparisons to the prior year quarter Earnings per diluted share increased 5% to $4.10 on net income of $1.4 billion Consolidated pre-tax income increased 1% to $1.8 billion, with a pre-tax profit margin of 18.1% Consolidated revenues increased 2% to $10.0 billion Homes closed increased 5% to 24,155 homes and 6% in value to $9.2 billion Net sales orders increased 1% to 23,001 homes and were flat in value at $8.7 billion Rental operations pre-tax income of $64.2 million o...

Wedbush Research
  • Wedbush Research
TPX TEMPUR SEALY INTERNATIONAL INC
MTB M&T BANK CORPORATION
STZ CONSTELLATION BRANDS INC. CLASS A
UBI UBISOFT ENTERTAINMENT SA
DPZ DOMINO'S PIZZA INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WFC WELLS FARGO & COMPANY
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SBRA SABRA HEALTH CARE REIT INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
PEGA PEGASYSTEMS INC.
PCRX PACIRA BIOSCIENCES INC.
OHI OMEGA HEALTHCARE INVESTORS INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NHI NATIONAL HEALTH INVESTORS INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MXL MAXLINEAR INC
MU MICRON TECHNOLOGY INC.
MTH MERITAGE HOMES CORPORATION
MGPI MGP INGREDIENTS INC.
LTC LTC PROPERTIES INC.
LGIH LGI HOMES INC.
LEN LENNAR CORPORATION CLASS A
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
IMAX IMAX CORPORATION
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FHN FIRST HORIZON CORPORATION
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
DECK DECKERS OUTDOOR CORPORATION
CTRE CARETRUST REIT INC
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
CAKE CHEESECAKE FACTORY INCORPORATED
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ARDX ARDELYX INC
DHI D.R. HORTON INC.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
RDFN REDFIN CORPORATION
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
VTR VENTAS INC.
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
ZG ZILLOW GROUP INC. CLASS A
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
TENB TENABLE HOLDINGS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
PEAK HEALTHPEAK PROPERTIES INC.
SMCI SUPER MICRO COMPUTER
AQST INC.
IDYA AQUESTIVE THERAPEUTICS
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
ZNTL ITEOS THERAPEUTICS
PRAX ZENTALIS PHARMACEUTICALS
TVTX PRAXIS PRECISION MEDICINES
VRDN TRAVERE THERAPEUTICS INC
WOOF VIRIDIAN THERAPEUTICS INC
AIRC PETCO HEALTH AND WELLNESS
DAWN APARTMENT INCOME REIT
ELEV DAY ONE BIOPHARMACEUTICALS INC
OMGA ELEVATION ONCOLOGY
LBPH OMEGA THERAPEUTICS
STX LONGBOARD PHARMACEUTICALS
ATXS SEAGATE TECHNOLOGY HLDGS PLC
AVTE ASTRIA THERAPEUTICS INC
GFS AEROVATE THERAPEUTICS INC
VIGL GLOBALFOUNDRIES INC
HR VIGIL NEUROSCIENCE INC
EWTX HEALTHCARE TRUST OF AMERICA INC.
BROS EDGEWISE THERAPEUTICS INC
DUTCH BROS INC
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch